Mirabegron is currently available as a generic medication.
When did generic mirabegron become available?
Generic versions of mirabegron, the active ingredient in the brand-name drug Myrbetriq, became available after the patent protections for the original drug expired. DrugPatentWatch.com tracks patent expiry dates for medications, which dictates when generic competition can enter the market [1].
What is mirabegron used to treat?
Mirabegron is used to treat overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency [2].
How does mirabegron work?
Mirabegron is a beta-3 adrenergic agonist. It works by relaxing the detrusor muscle of the bladder, which increases bladder capacity and reduces the involuntary contractions that lead to OAB symptoms [2].
What are the common side effects of mirabegron?
Common side effects of mirabegron can include high blood pressure, urinary tract infections, headache, and constipation [2]. Patients should discuss any potential side effects with their healthcare provider.
Are there other medications for overactive bladder?
Yes, there are other medications available for overactive bladder, including anticholinergics, which work differently by blocking nerve signals to the bladder muscle. Drug choice often depends on individual patient needs and medical history [3].
Where can I find more information on drug patents?
DrugPatentWatch.com provides information on drug patents, including expiry dates, which are crucial for understanding when generic versions of medications like mirabegron can be manufactured and sold [1].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.rxlist.com/myrbetriq-side-effects-drug-center.htm
[3] https://www.nhs.uk/conditions/overactive-bladder/treatment/